The United States represents the largest share of the Biomarker Tests Market, driven by its advanced healthcare infrastructure, strong focus on precision medicine, and significant investments in biomedical research. The country continues to lead in the adoption of innovative diagnostic technologies, particularly in oncology, cardiovascular diseases, and neurological disorders. Growing...